QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.104.071886v1 311/3/929    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hirsh, A. J. Articles by Boucher, R. C. Search for Related Content PubMed PubMed Citation Articles by Hirsh, A. J. Articles by Boucher, R. C. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Cystic Fibrosis Lung Diseases Hazardous Substances DB D-MANNITOL SODIUM

GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

Evaluation of Second Generation Amiloride Analogs as Therapy for Cystic Fibrosis Lung Disease

Parion Sciences, Durham, North Carolina (A.J.H., A.Z., R.T.S., S.H.); Cystic Fibrosis/Pulmonary Research and Treatment Center, School of Medicine, University of North Carolina, Chapel Hill, North Carolina (A.J.H., A.M.P., R.C.B.); and Division of Pulmonary and Critical Care Medicine, University of Miami at Mount Sinai Medical Center, Miami Beach, Florida (J.R.S., W.M.A.)

Epithelial sodium channel (ENaC) blockers have been proposed as a therapy to restore mucus clearance (MC) in cystic fibrosis (CF) airways. The therapeutic effects of the first generation ENaC blocker, amiloride, in CF patients, however, were minimal. Because the failure of amiloride reflected both its low potency and short duration of action on airway surfaces, we investigated whether the increased potency of benzamil and phenamil would produce more favorable pharmacodynamic properties. In vitro potency, maximal efficacy, rate of recovery from maximal block of ENaC, and rate of drug absorption were compared for amiloride, benzamil, and phenamil in cultured human and ovine bronchial epithelial cells. In both human and ovine bronchial epithelia, the rank order of potency was benzamil > phenamil » amiloride, the maximal efficacy was benzamil = phenamil = amiloride, the recovery to baseline sodium transport was phenamil < benzamil « amiloride, and the rate of drug absorption was phenamil > benzamil » amiloride. Based on greater potency, benzamil was compared with amiloride in in vivo pharmacodynamic studies in sheep, including tracheal mucus velocity (TMV) and MC. Benzamil enhanced MC and TMV, but acute potency or duration of effect did not exceed that of amiloride. In conclusion, our data support the hypothesis that ENaC blocker aerosol therapy increases MC. However, rapid absorption of benzamil from the mucosal surface offset its greater potency, making it equieffective with amiloride in vivo. More potent, less absorbable, third generation ENaC blockers will be required for an effective aerosol CF pharmacotherapy.

Address correspondence to: Dr. Andrew J. Hirsh, Parion Sciences Inc., 2525 Meridian Parkway, Suite 260, Durham, NC 27713. E-mail: ajhirsh{at}parion.com

This article has been cited by other articles:

				A. J. Hirsh, J. Zhang, A. Zamurs, J. Fleegle, W. R. Thelin, R. A. Caldwell, J. R. Sabater, W. M. Abraham, M. Donowitz, B. Cha, et al. Pharmacological Properties of N-(3,5-Diamino-6-chloropyrazine-2-carbonyl)-N'-4-[4-(2,3-dihydroxypropoxy)phenyl]butyl-guanidine Methanesulfonate (552-02), a Novel Epithelial Sodium Channel Blocker with Potential Clinical Efficacy for Cystic Fibrosis Lung Disease J. Pharmacol. Exp. Ther., April 1, 2008; 325(1): 77 - 88. [Abstract] [Full Text] [PDF]

				M. H. Levin, S. Sullivan, D. Nielson, B. Yang, W. E. Finkbeiner, and A. S. Verkman Hypertonic Saline Therapy in Cystic Fibrosis: EVIDENCE AGAINST THE PROPOSED MECHANISM INVOLVING AQUAPORINS J. Biol. Chem., September 1, 2006; 281(35): 25803 - 25812. [Abstract] [Full Text] [PDF]

				M. D. Carattino, S. Sheng, J. B. Bruns, J. M. Pilewski, R. P. Hughey, and T. R. Kleyman The Epithelial Na+ Channel Is Inhibited by a Peptide Derived from Proteolytic Processing of Its {alpha} Subunit J. Biol. Chem., July 7, 2006; 281(27): 18901 - 18907. [Abstract] [Full Text] [PDF]

				N. S. Joo, T. Irokawa, R. C. Robbins, and J. J. Wine Hyposecretion, Not Hyperabsorption, Is the Basic Defect of Cystic Fibrosis Airway Glands J. Biol. Chem., March 17, 2006; 281(11): 7392 - 7398. [Abstract] [Full Text] [PDF]

				H. A. Drummond, M. M. Furtado, S. Myers, S. Grifoni, K. A. Parker, A. Hoover, and D. E. Stec ENaC proteins are required for NGF-induced neurite growth Am J Physiol Cell Physiol, February 1, 2006; 290(2): C404 - C410. [Abstract] [Full Text] [PDF]

				J. R. Sabater, T. A. Lee, and W. M. Abraham Comparative Effects of Salmeterol, Albuterol, and Ipratropium on Normal and Impaired Mucociliary Function in Sheep Chest, November 1, 2005; 128(5): 3743 - 3749. [Abstract] [Full Text] [PDF]